Filing Details

Accession Number:
0001209191-14-004556
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-01-23 16:15:47
Reporting Period:
2014-01-21
Filing Date:
2014-01-23
Accepted Time:
2014-01-23 16:15:47
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
875320 Vertex Pharmaceuticals Inc / Ma VRTX Pharmaceutical Preparations (2834) 043039129
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1554979 E Megan Pace C/O Vertex Pharmaceuticals Incorporated
50 Northern Avenue
Boston MA 02210
Svp, Corp. Communications No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2014-01-21 1,250 $85.00 10,100 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Transaction made pursuant to Ms. Pace's company approved trading plan under Rule 10b5-1.